Thermo-chemo-radiotherapy for advanced gallbladder carcinoma

Area of Science:

• Oncology
• Medical Physics
• Surgical Oncology

Background:

• Advanced gallbladder carcinoma presents a dismal prognosis, often diagnosed at late stages.
• Aggressive surgical tumor removal yields limited success in advanced cases.
• Novel therapeutic strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the clinical effectiveness of thermo-chemo-radiotherapy (TCRT) for advanced gallbladder carcinoma.
• To compare TCRT with other treatment modalities, including surgery and supportive care.
• To assess tumor response and survival rates in patients with advanced gallbladder carcinoma.

Main Methods:

• A cohort of 270 patients with Stage VI advanced gallbladder carcinoma was analyzed.
• Patients were divided into five groups based on treatment: TCRT, R0-resection, R1/2-resection, chemo-/radiotherapy, and supportive care.
• Tumor regression, bile duct obstruction resolution, and survival rates were assessed for each group.

Main Results:

• TCRT demonstrated significant objective tumor responses, including complete and partial regressions.
• Resolution of bile duct obstruction was observed in a majority of treated patients.
• While R0-resection offered the best survival, TCRT and R1/2-resection showed significant long-term survival improvements compared to less intensive treatments.

Conclusions:

• Thermo-chemo-radiotherapy (TCRT) is an effective treatment for advanced gallbladder carcinoma, yielding significant tumor response and survival benefits.
• TCRT presents a viable and favorable alternative to aggressive surgical interventions for advanced gallbladder carcinoma.
• Further research into optimizing TCRT protocols may enhance outcomes for patients with advanced gallbladder cancer.